UBS O'Connor’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.04M | Sell |
37,602
-101,673
| -73% | -$2.81M | 0.05% | 194 |
|
|
2025
Q1 | $3.09M | Buy |
139,275
+39,643
| +40% | +$880K | 0.09% | 83 |
|
|
2024
Q4 | $1.97M | Buy |
99,632
+24,463
| +33% | +$484K | 0.05% | 155 |
|
|
2024
Q3 | $1.88M | Sell |
75,169
-38,826
| -34% | -$970K | 0.05% | 181 |
|
|
2024
Q2 | $2.13M | Buy |
113,995
+19,500
| +21% | +$364K | 0.06% | 181 |
|
|
2024
Q1 | $1.86M | Sell |
94,495
-6,227
| -6% | -$123K | 0.05% | 183 |
|
|
2023
Q4 | $1.77M | Sell |
100,722
-5,701
| -5% | -$100K | 0.06% | 186 |
|
|
2023
Q3 | $1.85M | Sell |
106,423
-115,000
| -52% | -$2M | 0.03% | 256 |
|
|
2023
Q2 | $3.12M | Buy |
221,423
+5,213
| +2% | +$73.4K | 0.07% | 185 |
|
|
2023
Q1 | $2.33M | Buy |
+216,210
| New | +$2.33M | 0.06% | 288 |
|
|
2022
Q4 | – | Sell |
-140,962
| Closed | -$1.81M | – | 167 |
|
|
2022
Q3 | $1.81M | Buy |
+140,962
| New | +$1.81M | 0.02% | 645 |
|